This inventor holds 40 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Asana Biosciences, LLC, Smithkline Beecham Corporation, Curadev Pharma Pvt Ltd. Active years: 1997-2024.
Location History:
- King of Prussia, PA (US) (2007 - 2009)
- Phoenixville, PA (US) (1997 - 2024)
Company Filing History:
21 out of 34 
13 out of 2,198 
2 out of 3 
Years Active: 1997-2024
Areas of Expertise:
Title: Scott Kevin Thompson: Innovator in Pharmaceutical Patents
Introduction
Scott Kevin Thompson, based in Phoenixville, PA, is a prominent inventor with an impressive portfolio of 40 patents. His work primarily focuses on innovative compounds and methods that have significant implications in the pharmaceutical industry. His latest inventions aim to address critical health challenges, particularly in pain management and cancer treatment.
Latest Patents
Among his latest patents, Thompson has developed P2X3 and P2X2/3 compounds that provide novel methods for regulating P2X receptors. These compounds show promise in treating pain and respiratory dysfunction by administering them to affected patients. Additionally, his work on heterocyclic inhibitors of ERK1 and ERK2 focuses on creating compounds that inhibit the ERK1/2 pathway, which is often dysregulated in various cancers. These inventions open avenues for treating diseases characterized by abnormal cellular proliferation.
Career Highlights
Thompson has made significant contributions to the field while working at notable companies such as Asana Biosciences, LLC and SmithKline Beecham Corporation. His extensive experience in pharmaceutical research and development has enabled him to innovate and patent numerous compounds that enhance therapeutic options.
Collaborations
Throughout his career, Thompson has collaborated with talented professionals, including Roger Astbury Smith and Tony Priestley. These partnerships have facilitated cross-disciplinary research, fueling innovative outcomes in drug development.
Conclusion
Scott Kevin Thompson stands out as a notable inventor whose contributions have the potential to transform therapeutic practices. His work on advanced pharmaceutical compounds not only reflects his expertise but also represents a commitment to improving patient care in significant ways.